| Phase I, open, multicenter study, with subcutaneous immunotherapy in depot presentation, in patients with rhinoconjunctivitis sensitized to Olea europaea. | Phase I, open, multicenter study, with subcutaneous immunotherapy in depot presentation, in patients with rhinoconjunctivitis sensitized to Olea europaea. | EUCTR2014-001569-29-ES |
| A study to evaluate the safety and tolerability of two different doses of Depigoid , Olea europaea and Salsola kali in subjects with allergic rhinitis or rhinoconjunctivitis, with or without controlled asthma. | A randomized (open-label design), parallel group, multicentre study to evaluate the safety and tolerability of two different doses of Depigoid 34% GrassesMix, 33% Olea europaea and 33% Salsola kali a 3000 DPP/ml in subjects with allergic rhinitis or rhinoconjunctivitis, with or without controlled asthma. | EUCTR2014-001571-31-ES |
| Ensayo clínico, multicéntrico, aleatorizado, doble ciego controlado con placebo, de inmunoterapia subcutánea con extracto despigmentado y polimerizado de polen de Olea europaea en pacientes con hipersensibilidad al polen de olivo. | Ensayo clínico, multicéntrico, aleatorizado, doble ciego controlado con placebo, de inmunoterapia subcutánea con extracto despigmentado y polimerizado de polen de Olea europaea en pacientes con hipersensibilidad al polen de olivo. | EUCTR2006-005727-41-ES |
| A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea | A Phase I Multicenter, Open Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea | NCT02849210 |
| Ensayo clínico prospectivo, randomizado, doble ciego, paralelo, controlado frente a placebo de inmunoterapia sublingual con extracto alergénico despigmentado y polimerizado con glutaraldehído de Olea europaea, en dos grupos de pacientes con sintomatología de rinitis o rinoconjuntivitis alérgica. | Ensayo clínico prospectivo, randomizado, doble ciego, paralelo, controlado frente a placebo de inmunoterapia sublingual con extracto alergénico despigmentado y polimerizado con glutaraldehído de Olea europaea, en dos grupos de pacientes con sintomatología de rinitis o rinoconjuntivitis alérgica. | EUCTR2006-001130-41-ES |
| Evaluation of the effects of a Polyherbal compound in the treatment of kindney stone disease | Investigating the herbal combination of Olea europaea leaf, Tribulus terrestris, Alhagi and zea mays on patients with kidney stone: a pre- and post-treatment comparative study | IRCT20151230025772N6 |
| Biological standardization of pollen of Phleum pratense, Olea europaea, mite extract Dermatophagoides pteronyssinus and animal allergen Felis domesticus. | Biological standardization of pollen of Phleum pratense, Olea europaea, mite extract Dermatophagoides pteronyssinus and animal allergen Felis domesticus. Open label, single center, phase II study. | EUCTR2012-005362-35-ES |
| Evaluation of the effect of edible herbal medicine in decreasing mortality and hospitalization of patients with COVID-19. | Evaluation of the effect of edible herbal medicine (containing Colchicum autumnale, Olea Europaea, Nigella sativa, Lavandula angustifolia, Zingiber officinale) in decreasing mortality and hospitalization duration in a severe and critical phase of patients with COVID-19. | IRCT20200825048515N49 |
| Safety clinical trial with depigmented and polymerized allergenic extracts of a pollen combination: Depigoid 50% Grasses/50% Olea europaea (2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria judaica (2000DPP/ml). | Prospective, open uncontrolled study to evaluate the safety of Depigoid with two pollen combinations ( Grasses/Olea and Grasses/ Parietaria) 2000 DPP/ml in patients with allergic rhinitis or rhinoconjunctivitis with or without seasonal asthma. | EUCTR2012-001699-12-ES |
| Ensayo clínico aleatorizado, doble ciego, doble dummy, controlado con placebo, para valorar la eficacia y seguridad de diferentes presentaciones de inmunoterapia subcutánea en pacientes asmáticos sensibilizados a Olea europaea y Lolium perenne | Ensayo clínico aleatorizado, doble ciego, doble dummy, controlado con placebo, para valorar la eficacia y seguridad de diferentes presentaciones de inmunoterapia subcutánea en pacientes asmáticos sensibilizados a Olea europaea y Lolium perenne | EUCTR2004-004317-42-ES |
